C1 inhibitor prevents capillary leakage after thermal trauma

Critical Care Medicine

Volumn 28, Issue 9, 2000, Pages 3224-3232

  Radke, Alexander ^a   Mottaghy, Khosrow ^a   Goldmann, Christine ^a   Khorram Sefat, Ramin ^a   Kovacs, Birgit ^a,b   Janssen, Alfons ^c   Klosterhalfen, Bernd ^a,b   Hafemann, Bernd ^a   Pallua, Norbert ^a   Kirschfink, Michael ^d  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c Emil Von Behring Str 76 35041   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Animal model; Burns; C1 inhibitor; Capillary leakage; Complement; Complement activation; Complement analysis; Immunology; Inflammation; Pigs; Therapy

Indexed keywords

BERINERT; COMPLEMENT COMPONENT C1S INHIBITOR; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL TRANSLOCATION; CAPILLARY LEAK SYNDROME; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFICACY; EDEMA; HISTOPATHOLOGY; INTRAVENOUS ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REMISSION; SCALD; SWINE; TREATMENT OUTCOME;

EID: 0033801237     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200009000-00018     Document Type: Article

References (55)

1. Immunologic defense against infection: Alterations following thermal injuries
2. What are the immunological alterations induced by burn injury?
3. Mechanism of immunologic suppression in burn injury
4. Characterisation of the immunosuppressive effect of burned tissue in an animal model
5. Complement-mediated hemodynamic depression in the early postburn period
6. The effect of thermal injury on hemodynamic, respiratory, and hematologic variables in relation to complement activation
7. Pathophysiologic events related to thermal injury of skin
8. Multiple organ failure in patients with thermal injury
9. Cause of mortality in thermally injured patients
10. Biochemical investigations after burn injury: Complement system, protease-antiprotease balance and acute phase reactants
11. Accumulation of anaphylatoxins and terminal complement complexes in inflammatory fluids
12. Endotoxinemia and complement activation after severe burn injuries - Effects on leukocytes, soluble selectins, and inflammatory cytokines
13. Preferential activation and depletion of the alternative complement pathway by burn injury
14. Biochemistry and biology of anaphylatoxins
15. Roles of histamine, complement and xanthine oxidase in thermal injury of skin
16. Neutrophil activation after burn injury: Contributions of the classic complement pathway and of endotoxin
17. Neutrophil activation in thermal injury as assessed by increased expression of complement receptors
18. The role of mediators in the response to thermal injury
19. Plasma prokallikrein and kininogens in burned patients
20. Relationship among the complement, kinin, clotting, and fibrinolytic systems
21. Controlling the complement system
22. In vitro effects of complement inactivation upon burn-associated cell-mediated immunosuppression
23. Biochemistry and physiology of human C1-inhibitor: Current issues
24. Inactivation of kallikrein in human plasma
25. Inhibition by C1-INH of Hageman factor fragment activation of coagulation, fibrinolysis, and kinin generation
26. Postburn edema and related changes in interleukin-2, leukocytes, platelet activation, endothelin-1, and C1 esterase inhibitor
27. Proteolytic inactivation of plasma C1-inhibitor in sepsis
28. Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome
29. Long-term prophylaxis with C1-inhibitor concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiency
30. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2
31. C1 inhibitor in anti-inflammatory therapy: From animal experiment to clinical application
32. Assay and properties of serum inhibitor of C1-esterase
33. Complement and complement fixation
34. A study of optimal reaction conditions for an assay of the human alternative pathway
35. Observation on a proesterase associated with partially purified first component of human complement (C1)
36. Complement activation in septic baboons detected by neoepitope specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC)
37. Intestinal mucosal lesion in low-flow states I. A morphological, hemodynamic and metabolic re-appraisal
38. Half-life of C1-INH in hereditary angioneurotic edema (HAE)
39. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury
40. Anti-C5a suppresses post-traumatic permeability damage of the lung after severe burn trauma
41. Antibody independent interaction between Escherichia coli J5 and human complement components
42. Interactions of C-reactive protein with the first component of human complement
43. Activation of complement by cytoskeletal intermediate filaments
44. Nonimmune activation of the classical pathway of complement
45. Neutrophil disorders in burn injury: Complement, cytokines, and organ injury
46. Organ damage is preceded by changes in protein extravasation in an experimental model of multiple organ failure
47. Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome
48. Systemic complement activation produces hemodynamic changes characteristic of sepsis
49. Methods to detect and quantitate complement activation
50. The first component of human complement (C1): Activation and control
51. The influence of the C1-inhibitor BERINERT® and the protein-free haemodialysate ACTIH-AEMYL20%® on the evolution of the depth of scalded bums in a porcine model
52. Bacterial translocation after thermal injury
53. The therapeutic effect of C1-inhibitor on gut-derived bacterial translocation following thermal injury
54. C1-esterase inhibitor (C1-Inh) as adjuvant therapy for septic shock following severe thermal trauma